LAKE OSWEGO, OR, April 6, 2018 Medica Holdings, Inc. is pleased to announce that the Medicant Mucosal Atomizer (MMA), has received 510(k) clearance from the United States Food & Drug Administration (FDA). The MMA allows for the non-invasive delivery of medication directly to a patient’s blood stream via their mucosal membranes. The device will be available in three styles; MMA Rhinal™ for nasal applications, 4.5” and 8.5” for delivery directly to the laryngo-tracheal region via a wand-like configuration. The MMA Rhinal™ is for use with drugs approved for intranasal delivery, all supplied with a 3 cc syringe.
|
|
RSS Feed